Reduction Of The Prophylactic Effect Of Tixagevimab-Cilgavimab In The Omicron Era In Patients With Hematological Malignancies And Without Antibody Response Following Sars-Cov-2 Vaccination.
Tixagevimab-Cilgavimab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Reduction Of The Prophylactic Effect Of Tixagevimab-Cilgavimab In The Omicron Era In Patients With Hematological Malignancies And Without Antibody Response Following Sars-Cov-2 Vaccination. ### Output: Tixagevimab-Cilgavimab